A phase III, randomized, double-blind, placebo-controlled study of peldesine (BCX-34) cream as topical therapy for cutaneous T-cell lymphoma-Reference-Cited by-同舟云学术

A phase III, randomized, double-blind, placebo-controlled study of peldesine (BCX-34) cream as topical therapy for cutaneous T-cell lymphoma

Published:2001-06 Issue:6 Volume:44 Page:940-947
ISSN:0190-9622
Container-title:Journal of the American Academy of Dermatology
language:en
Short-container-title:Journal of the American Academy of Dermatology

Author:

Duvic Madeleine,Olsen Elise A.,Omura George A.,Maize John C.,Vonderheid Eric C.,Elmets Craig A.,Shupack Jerome L.,Demierre Marie-France,Kuzel Timothy M.,Sanders Deborah Y.

Publisher

Elsevier BV

Subject

Dermatology

Reference14 articles.

1. Mycosis fungoides and Sézary syndrome;Diamandidou;Blood,1996

2. Systemic therapy of cutaneous T-cell lymphomas (mycosis fungoides and the Sézary syndrome);Bunn;Ann Intern Med,1994

3. Mycosis fungoides and the Sézary syndrome: a review of pathogenesis, diagnosis, and therapy;Kuzel;J Clin Oncol,1991

4. Mycosis fungoides. Ergebnisse einer Helioklimatherapie im Hochgebirge (Davos, 1560 m);Tippel;Hautarzt,1986

5. Nucleoside-phosphorylase deficiency in a child with severely defective T-cell immunity and normal B-cell immunity;Giblett;Lancet,1975

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Perspectives and challenges in developing small molecules targeting purine nucleoside phosphorylase;European Journal of Medicinal Chemistry;2024-05

2. Cutaneous Lymphomas;Rook's Textbook of Dermatology;2024-03-19

3. EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome – Update 2023;European Journal of Cancer;2023-12

4. Design, Synthesis, Biological Evaluation, and Crystallographic Study of Novel Purine Nucleoside Phosphorylase Inhibitors;Journal of Medicinal Chemistry;2023-05-03

5. Suggested Guidelines for the Treatment of Mycosis Fungoides in Countries with Limited Resources;Dermatology Research and Practice;2023-01-31